REQUEST A DEMO
Total
USD $0.00
Search more companies

Urtica Sp. z o.o. (Poland)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Urtica Sp. z o.o. Profile Updated: July 24, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Urtica Sp. z o.o. is a company located in Wroclaw, Poland. They are the largest distributor of drugs for closed healthcare and one of the largest pharmaceutical wholesalers in the country. They provide comprehensive support and strategy for the implementation and distribution of medicinal products in the Polish market. With over 30 years of experience, they have successfully introduced thousands of drugs to the Polish market.

Headquarters
Ul. Krzemieniecka 120
Wroclaw; Dolnoslaskie; Postal Code: 54-613

Contact Details: Purchase the Urtica Sp. z o.o. report to view the information.

Website: http://www.urtica.pl

Basic Information
Total Employees:
Purchase the Urtica Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Urtica Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Urtica Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Urtica Sp. z o.o. report to view the information.
Incorporation Date:
May 20, 2002
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
"Pharmalink" Sp. z o.o.
100%
Lideo S.A.
100%
Company Performance
Financial values in the chart are available after Urtica Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
24.2%
Total operating revenue
24.22%
Operating profit (EBIT)
40.35%
EBITDA
37.69%
Net Profit (Loss) for the Period
38.9%
Total assets
30.52%
Total equity
86.53%
Operating Profit Margin (ROS)
0.16%
Net Profit Margin
0.23%
Return on Equity (ROE)
-11.49%
Debt to Equity Ratio
-0.8%
Quick Ratio
0.01%
Cash Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?